shutterstock_314149679_canadastock

canadastock / Shutterstock.com

13 February 2020Big PharmaIQPC Exchange

Global IP Exchange Europe: IP leaders’ investment priorities revealed

In such a fast-moving and exciting area for many brands, the survey uncovered the specific challenges participants are facing in bringing their IP strategies to life.

Already registered?

Login to your account

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More features

EPO delivers key Novo Nordisk, GSK and Inhibrx rulings

SCOTUS denies Alvogen unit's appeal to sell Bausch Xifaxan generic

GSK triumphs in EPO appeal, revoking Pfizer patent

Teva fights for re-listing of inhaler patents at US appeals court

China’s new policies on foreign investment in healthcare and biotech

Startup CFO’s betrayal is a lesson in preparing for the worst

Sandoz lands reduced antitrust award of $70m

Teva faces $500m fine for antitrust breaches over MS drug